CC-1088
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
CC-1088 is a thalidomide analogue inhibitor of phosphodiesterase 4 that was being developed up to 2005 by Celgene Corp., for treating of inflammatory diseases and myelodysplastic syndromes. Apremilast (CC-10004) was found to be a preferable.
CC-1088 is a thalidomide analogue inhibitor of phosphodiesterase 4 that was being developed up to 2005 by Celgene Corp., for treating of inflammatory diseases and myelodysplastic syndromes. Apremilast (CC-10004) was found to be a preferable.
See also
Apremilast Development of analogs of thalidomide
References
External links
NCI Thesaurus
Text derived from https://en.wikipedia.org/w/index.php?oldid=1297112918 under CC BY-SA 4.0; modifications have been made.